UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	June 16, 2021 4:00 P.M.

Form:	S-1
CIK: 0001806952 Company Name: Lyell Immunopharma, Inc. File Number: 333-256470